Formula Growth LTD Albemarle Corp Transaction History

Formula Growth LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$113.26 - $170.8 $1.36 Million - $2.05 Million	12,000 New	12,000 $1.73 Million
Q2 2022 Aug 12, 2022	SELL	$187.76 - $270.92 $3.94 Million - $5.69 Million	-21,000 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$172.09 - $246.0 $3.61 Million - $5.17 Million	21,000 New	21,000 $4.64 Million
Q1 2020 May 14, 2020	SELL	$50.9 - $94.31 $4.93 Million - $9.13 Million	-96,785 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$60.74 - $73.04 $5.88 Million - $7.07 Million	96,785 New	96,785 $7.07 Million

919

104M

8.35M

14.3M

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $9.06B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

Get notified when there are updates to the investment portfolio of Formula Growth LTD, based on Form 13F filings with the SEC.

Stay updated on Formula Growth LTD with notifications on news.